The emerging role of nimotuzumab in the treatment of non-small cell lung cancer
William Boland1, Gwyn Bebb2,31Department of Anatomy and Cell Biology, McGill University, Montreal, Quebec, Canada; 2Tom Baker Cancer Centre, Calgary, Alberta, Canada; 3University of Calgary, Calgary, Alberta, CanadaAbstract: Current non-small cell lung cancer (NSCLC) chemotherapy and radiotherapy re...
Guardado en:
Autores principales: | William Boland, Gwyn Bebb |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8182e1b313a0478e8099dcde220e23cc |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Nimotuzumab, a novel monoclonal antibody to the epidermal growth factor receptor, in the treatment of non-small cell lung cancer
por: Takeda M, et al.
Publicado: (2011) -
Focus on the potential role of ficlatuzumab in the treatment of non-small cell lung cancer
por: D'Arcangelo M, et al.
Publicado: (2013) -
Clinical use of crizotinib for the treatment of non-small cell lung cancer
por: Roberts PJ
Publicado: (2013) -
Management of patients with advanced non-small cell lung cancer: role of gefitinib
por: Vamsidhar Velcheti, et al.
Publicado: (2010) -
New targeted treatments for non-small-cell lung cancer – role of nivolumab
por: Zago G, et al.
Publicado: (2016)